Vericel (VCEL) Tax Provisions (2020 - 2024)
Vericel (VCEL) reported Tax Provisions of $148000.0 for Q4 2024, down 86.55% on a YoY basis from $1.1 million in Q1 2024, and down 86.55% sequentially from $1.1 million in Q4 2023.
Vericel (VCEL) Tax Provisions (2020 - 2024) Analysis & Trends
Vericel (VCEL) has 5 years of Tax Provisions data on file, last reported at $148000.0 in Q4 2024.
- For the quarter ending Q4 2024, Tax Provisions fell 86.55% year-over-year to $148000.0; the trailing twelve-month figure through Dec 2024 stood at $962000.0 (down 37.33% YoY), and the FY2025 full-year result was $859000.0, up 480.41% from the prior year.
- Tax Provisions fell to $148000.0 in Q4 2024, from $1.1 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1.1 million in Q4 2023 to a low of -$326000.0 in Q4 2021.
- A 5-year average of $194666.7 and a median of $143000.0 in 2021 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions jumped 314.72% in 2022 and plunged 1461.9% in 2023, its largest moves.
- Tracing VCEL's Tax Provisions over 5 years: stood at $180000.0 in 2020, then tumbled by 281.11% to -$326000.0 in 2021, then jumped by 314.72% to $700000.0 in 2022, then jumped by 57.14% to $1.1 million in 2023, then slumped by 86.55% to $148000.0 in 2024.
- Business Quant data shows VCEL's Tax Provisions at $148000.0 in Q4 2024, $1.1 million in Q4 2023, and -$286000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 148,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | -286,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Sep 30, 2022 | 21,000.00 |
| Dec 31, 2021 | -326,000.00 |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 143,000.00 |
| Dec 31, 2020 | 180,000.00 |